Gossamer Bio (GOSS) Tax Rate (2024 - 2025)
Gossamer Bio (GOSS) posted quarterly Tax Rate of 0.19% for Q4 2025, down 661.0% year-over-year from 0.03% in Q4 2024, and down 97.27% quarter-over-quarter from 6.8% in Q4 2024.
Gossamer Bio (GOSS) Tax Rate (2024 - 2025) Analysis & Trends
Gossamer Bio's Tax Rate history runs 2 years deep, the most recent figure standing at 0.19% for Q4 2025.
- In Q4 2025, Tax Rate fell 661.0% year-over-year to 0.19%; the TTM figure through Dec 2025 stood at 1.44% (up 297.0% YoY), while the FY2025 annual figure was 0.05%, up 166.0% from the prior year.
- Tax Rate for Q4 2025 stood at 0.19%, down from 6.8% in the prior quarter.
- The five-year high for Tax Rate was 8.2% in Q2 2024, with the low at 0.19% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - | - |
| 10 | Gossamer Bio | 50.88 Mn | -6.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.19% |
| Dec 31, 2025 | 0.19% |
| Dec 31, 2025 | 0.19% |
| Dec 31, 2024 | 6.80% |
| Dec 31, 2024 | 6.80% |
| Dec 31, 2024 | 6.80% |
| Sep 30, 2024 | 3.44% |
| Sep 30, 2024 | 3.44% |
| Sep 30, 2024 | 3.44% |
| Jun 30, 2024 | 8.20% |
| Jun 30, 2024 | 8.20% |
| Jun 30, 2024 | 8.20% |